Die Cannabis-Onlineapotheke Cannalivery und Cansativa, Marktführer im medizinischen Cannabis-Markt, gehen ab sofort eine strategische Partnerschaft ein.Durch diese Zusammenarbeit wird dasstetig wachsende Partnernetzwerk genutzt, umdie Versorgung von Cannabis-Patient:innen in Deutschland zu verbessern. Eine der zentralen Verbesserungen, die aus der Partnerschaft hervorgehen, ist die schnelle Lieferung von einer noch größeren Produktauswahl von Cannabismedikamenten. Bereits jetzt garantiert Cannalivery eine Lieferzeit von nicht mehr als 48 Stunden. Das Ziel von Cannalivery, bereits 2024 innerhalb von 420 Minuten bundesweit auszuliefern, deckt sich mit dem Anspruch des Cansativa-Partnerprogramms, eine starke regionale Versorgung von Medizinalcannabis in Deutschland zu sichern.

Cansativa GmbH („Cansativa Group“), Tilray Medical and Olikla s.r.o (“Olikla”) are pleased to announce a new strategic partnership that will enable the export of Tilray Medical cannabis from Germany to the Czech Republic. This collaboration allows Olikla to provide a selection of Tilray Medical products from Cansativa’s distribution portfolio to their broad network of pharmacies and hospitals. This partnership is expected to generate immediate turnover. "We are very excited to be working with Olikla to bring medical cannabis products to patients in the Czech Republic," said CEO and co-founder Benedikt Sons. "This partnership is a testament to the growing recognition of the medical benefits of cannabis and the importance of providing patients with access to a wide range of EU-GMP certified, high-quality Tilray Medical products." Czech Republic is witnessing a growing market for medical cannabis. The country has been actively working towards the legalization and regulation of medical cannabis, and this partnership will help to ensure that Czech patients have access to high quality medical cannabis products. Olikla CEO Jan Šimon added "We are thrilled to be working with Cansativa and Tilray Medical to bring their product diversity of medical cannabis products to our market. This partnership will be a significant boost to the already growing market of medical cannabis in the Czech Republic, and we look forward to a long and successful collaboration." About Cansativa Group Cansativa Group is the market leader in the medical cannabis market and sees itself as a driving force of the cannabis industry in Germany. Since the award by the Federal Institute for Drugs and Medical Devices (BfArM) in August 2020, they are the only company commissioned for the distribution of medical cannabis from German cultivation. In the upcoming cannabis legalization, Cansativa Group sees itself as a pioneer in the democratization of the cannabis market. Connect with Cansativa Group: Website | LinkedIn About Olikla Olikla is a family-run distributor that offers comprehensive pharmaceutical services to partners placing their products in the CZ market, distributes generic drugs, medical devices and provides exclusive distribution representations. About Tilray Medical Tilray Medical, a division of Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), is dedicated to transforming lives and fostering dignity for patients in need through safe and reliable access to a global portfolio of medical cannabis brands, including Tilray, Aphria, Broken Coast, Symbios, and Navcora. Tilray Medical grew from being one of the first companies to become an approved licensed producer of medical cannabis in Canada to building the first GMP-certified cannabis production facilities in Europe, first in Portugal and later in Germany. Today, Tilray Medical is one of the biggest suppliers of medical cannabis brands to patients, physicians, hospitals, pharmacies, researchers, and governments, in over 20 countries and across five continents. For more information on Tilray Medical please visit, www.Tilray.com and follow @Tilray on all social platforms.

After launching a new premium medical cannabis brand under the name “AMICI” in Mid-November, Cansativa Group, Germany’s leading cannabis platform, now closes the year of 2022 with a new high THC product, which sets itself at the top of the medical cannabis market. The previously launched product line consists of the two types “Strawberry Banana” and “Cherry Pie” and features high microbiological purity beside particular product details, which have been tested by experts and patients in the last weeks.